| 标题 |
LBA40 Primary results from the phase III ALTN-AK105-III-02 study: Anlotinib plus penpulimab versus sorafenib as first-line (1L) therapy for advanced hepatocellular carcinoma (aHCC) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:Jin Zhou; Jie Fan; Shunchang Jiao; Li Bai; Jia Luo; et al 出版日期:2024-09-01 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)